353 related articles for article (PubMed ID: 27861189)
1. Oral anticoagulation for stroke prevention amongst atrial fibrillation patients with valvular heart disease: an update.
Ha AC; Verma A; Verma S
Curr Opin Cardiol; 2017 Mar; 32(2):174-180. PubMed ID: 27861189
[TBL] [Abstract][Full Text] [Related]
2. Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.
Potpara TS; Lip GY; Larsen TB; Madrid A; Dobreanu D; Jędrzejczyk-Patej E; Dagres N;
Europace; 2016 Oct; 18(10):1593-1598. PubMed ID: 27876696
[TBL] [Abstract][Full Text] [Related]
3. Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation?
Anderson SL; Marrs JC
Curr Cardiol Rep; 2019 Aug; 21(10):118. PubMed ID: 31473836
[TBL] [Abstract][Full Text] [Related]
4. Direct oral anticoagulant use in nonvalvular atrial fibrillation with valvular heart disease: a systematic review.
Owens RE; Kabra R; Oliphant CS
Clin Cardiol; 2017 Jun; 40(6):407-412. PubMed ID: 28004413
[TBL] [Abstract][Full Text] [Related]
5. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial.
De Caterina R; John Camm A
Europace; 2016 Jan; 18(1):6-11. PubMed ID: 26450845
[TBL] [Abstract][Full Text] [Related]
6. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and bioprosthetic valves: A meta-analysis.
Yokoyama Y; Briasoulis A; Ueyama H; Mori M; Iwagami M; Misumida N; Takagi H; Kuno T
J Thorac Cardiovasc Surg; 2023 Jun; 165(6):2052-2059.e4. PubMed ID: 34417050
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Lip GYH; Collet JP; Caterina R; Fauchier L; Lane DA; Larsen TB; Marin F; Morais J; Narasimhan C; Olshansky B; Pierard L; Potpara T; Sarrafzadegan N; Sliwa K; Varela G; Vilahur G; Weiss T; Boriani G; Rocca B;
Europace; 2017 Nov; 19(11):1757-1758. PubMed ID: 29096024
[TBL] [Abstract][Full Text] [Related]
8. Long-term oral anticoagulation for atrial fibrillation in low and middle income countries.
Ramakumar V; Benz AP; Karthikeyan G
Indian Heart J; 2021; 73(2):244-248. PubMed ID: 33865530
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis. The Loire Valley Atrial Fibrillation Project.
Philippart R; Brunet-Bernard A; Clementy N; Bourguignon T; Mirza A; Angoulvant D; Babuty D; Lip GY; Fauchier L
Thromb Haemost; 2016 May; 115(5):1056-63. PubMed ID: 26843425
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Prognostic Implications of Valve Disease in Patients With Atrial Fibrillation Initiating Direct Oral Anticoagulants.
Caro Martínez C; Elvira Ruiz G; Flores Blanco PJ; Cerezo Manchado JJ; Albendín Iglesias H; Lova Navarro A; Arregui Montoya F; García Alberola A; Pascual Figal DA; Bailén Lorenzo JL; Manzano Fernández S
Rev Esp Cardiol (Engl Ed); 2019 Nov; 72(11):935-943. PubMed ID: 30497945
[TBL] [Abstract][Full Text] [Related]
11. Direct oral anticoagulants use in elderly patients with non valvular atrial fibrillation: state of evidence.
Benedetti G; Neccia M; Agati L
Minerva Cardioangiol; 2018 Jun; 66(3):301-313. PubMed ID: 29125269
[TBL] [Abstract][Full Text] [Related]
12. Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
van Nieuwenhuizen KM; van der Worp HB; Algra A; Kappelle LJ; Rinkel GJ; van Gelder IC; Schutgens RE; Klijn CJ;
Trials; 2015 Sep; 16():393. PubMed ID: 26340977
[TBL] [Abstract][Full Text] [Related]
13. How to define valvular atrial fibrillation?
Fauchier L; Philippart R; Clementy N; Bourguignon T; Angoulvant D; Ivanes F; Babuty D; Bernard A
Arch Cardiovasc Dis; 2015 Oct; 108(10):530-9. PubMed ID: 26184867
[TBL] [Abstract][Full Text] [Related]
14. Timing of anticoagulation after recent ischaemic stroke in patients with atrial fibrillation.
Seiffge DJ; Werring DJ; Paciaroni M; Dawson J; Warach S; Milling TJ; Engelter ST; Fischer U; Norrving B
Lancet Neurol; 2019 Jan; 18(1):117-126. PubMed ID: 30415934
[TBL] [Abstract][Full Text] [Related]
15. [Antithrombotic treatment of patients with valvular atrial fibrillation].
Bovin A; Christensen TD; Grove EL
Ugeskr Laeger; 2017 Jul; 179(29):. PubMed ID: 28789760
[TBL] [Abstract][Full Text] [Related]
16. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Avezum A; Lopes RD; Schulte PJ; Lanas F; Gersh BJ; Hanna M; Pais P; Erol C; Diaz R; Bahit MC; Bartunek J; De Caterina R; Goto S; Ruzyllo W; Zhu J; Granger CB; Alexander JH
Circulation; 2015 Aug; 132(8):624-32. PubMed ID: 26106009
[TBL] [Abstract][Full Text] [Related]
17. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.
Heidbuchel H; Verhamme P; Alings M; Antz M; Diener HC; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
Europace; 2015 Oct; 17(10):1467-507. PubMed ID: 26324838
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation in Atrial Fibrillation Associated with Mitral Stenosis.
da Silva RMFL
Cardiovasc Hematol Agents Med Chem; 2022; 20(3):172-174. PubMed ID: 35319395
[TBL] [Abstract][Full Text] [Related]
19. Is There a Role for Vitamin K Antagonist in the Management of Atrial Fibrillation in 2023?
Burg MR; Ha ACT
Curr Cardiol Rep; 2023 May; 25(5):391-399. PubMed ID: 36995540
[TBL] [Abstract][Full Text] [Related]
20. A Bridge to Nowhere? Benefits and Risks for Periprocedural Anticoagulation in Atrial Fibrillation.
Krishnamoorthy A; Ortel T
Curr Cardiol Rep; 2016 Oct; 18(10):101. PubMed ID: 27568795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
